Medroxyprogesterone acetate and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Medroxyprogesterone acetate (medroxyprogesterone acetate) and Decadron (dexamethasone). Common drug interactions include toothache among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Medroxyprogesterone acetate and Decadron. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Medroxyprogesterone acetate?

Medroxyprogesterone acetate has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 12,600 Medroxyprogesterone acetate users. Check the latest studies of Medroxyprogesterone acetate.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.



On Jul, 13, 2026

22 people who take Medroxyprogesterone acetate and Decadron together, and have interactions are studied.

Medroxyprogesterone acetate and Decadron drug interactions.

What are the common drug interactions of Medroxyprogesterone Acetate and Decadron, by gender? *:

female:

  1. Toothache (tooth pain)
  2. Trousseau's syndrome (the trousseau sign of malignancy is a medical sign found in certain cancers that is associated with venous thrombosis and hypercoagulability)
  3. Urinary tract infection
  4. Viral infection
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pneumonia
  7. Leukopenia (less number of white blood cells in blood)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  10. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)

male:

  1. Anaemia (lack of blood)
  2. Anxiety
  3. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  4. Chest pain
  5. Conjunctival haemorrhage (bleeding underneath the conjunctiva)
  6. Dyspnoea (difficult or laboured respiration)
  7. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  8. Fatigue (feeling of tiredness)
  9. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  10. Hypercalcaemia (elevated calcium (ca+) level in the blood)

What are the common drug interactions of Medroxyprogesterone Acetate and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Leukopenia (less number of white blood cells in blood)
  2. Pneumonia
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  6. Anaemia (lack of blood)
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Infection
  9. Menstruation irregular
  10. Metrorrhagia (uterine bleeding at irregular intervals)

50-59:

  1. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Vomiting
  4. Nausea (feeling of having an urge to vomit)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Alanine aminotransferase increased
  7. Alopecia (absence of hair from areas of the body)
  8. Anxiety
  9. Aspartate aminotransferase increased
  10. Bone pain

60+:

  1. Neuropathy peripheral (surface nerve damage)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Back pain
  4. Balance disorder
  5. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  6. Blood disorder
  7. Blood phosphorus decreased
  8. Bone disorder
  9. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  10. Bone sarcoma (bone cancer)

What are the existing conditions these people have? *

  1. Metastases To Lung (cancer spreads to lung): 9 people, 40.91%
  2. Metastases To Liver (cancer spreads to liver): 9 people, 40.91%
  3. Metastases To Bone (cancer spreads to bone): 9 people, 40.91%
  4. Breast Cancer Recurrent: 9 people, 40.91%
  5. Constipation: 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Medroxyprogesterone acetate and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Medroxyprogesterone acetate and Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Medroxyprogesterone acetate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Decadron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Medroxyprogesterone acetate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decadron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate and dexamethasone (the active ingredients of Medroxyprogesterone acetate and Decadron, respectively), and Medroxyprogesterone acetate and Decadron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: